Calamos Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Calamos Advisors’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,987	Closed	-$1.14M	–	1015
2023 Q2	$1.14M	Buy	+3,987	New	+$1.11M	0.01%	695
2023 Q1	–	Sell	-16,089	Closed	-$3.31M	–	1242
2022 Q4	$3.31M	Sell	16,089 -12,047	-43%	-$3.05M	0.02%	734
2022 Q3	$7.82M	Buy	28,136 +2,401	+9%	+$611K	0.04%	557
2022 Q2	$4.92M	Buy	25,735 +2,246	+10%	+$396K	0.02%	714
2022 Q1	$4.87M	Sell	23,489 -3,997	-15%	-$659K	0.02%	737
2021 Q4	$4.9M	Sell	27,486 -581	-2%	-$115K	0.02%	725
2021 Q3	$5.78M	Buy	28,067 +19,041	+211%	+$3.74M	0.03%	569
2021 Q2	$1.71M	Buy	+9,026	New	+$1.48M	0.01%	752

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Calamos Advisors's SWAV Position: Q3 2023 in Review

Calamos Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 3,987 shares — an estimated $1.14M sold.

Calamos Advisors first reported a position in SWAV in Q2 2021 and held it in 8 quarters. The position peaked at $7.82M in Q3 2022. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

Calamos Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Calamos Advisors sold 3,987 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $1.14M.
Calamos Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
Calamos Advisors's Shockwave Medical, Inc. Common Stock position peaked at $7.82M in Q3 2022.
412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Calamos Advisors's 13F filing for Q3 2023, filed 26 Oct 2023.